华纳药厂
(688799)
| 流通市值：40.18亿 | | | 总市值：40.18亿 |
| 流通股本：9380.00万 | | | 总股本：9380.00万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 336,233,032.74 | 1,412,949,151.44 | 1,069,303,325.98 | 738,594,469.49 |
| 营业收入 | 336,233,032.74 | 1,412,949,151.44 | 1,069,303,325.98 | 738,594,469.49 |
| 二、营业总成本 | 294,233,734.5 | 1,256,390,079.35 | 924,380,616.39 | 634,765,915.77 |
| 营业成本 | 123,601,457.63 | 542,148,384.27 | 402,683,130.21 | 274,932,507.52 |
| 税金及附加 | 3,105,201.57 | 25,776,310.19 | 18,089,062.56 | 11,746,584.77 |
| 销售费用 | 120,761,759.96 | 480,365,786.52 | 369,270,409.74 | 250,922,657.6 |
| 管理费用 | 23,245,747.77 | 66,892,928.37 | 47,079,440.34 | 32,810,327.22 |
| 研发费用 | 26,602,707.31 | 158,332,123.84 | 100,556,753.85 | 66,469,596.95 |
| 财务费用 | -3,083,139.74 | -17,125,453.84 | -13,298,180.31 | -2,115,758.29 |
| 其中:利息费用 | - | 17,209.8 | - | - |
| 其中:利息收入 | 3,190,026.23 | 16,836,850.45 | 13,679,371.81 | 1,986,239.56 |
| 加:投资收益 | 535,543.58 | -18,662,074.42 | -11,400,345.34 | -4,140,800.94 |
| 资产减值损失(新) | -10,322.63 | -11,114,286.28 | -2,414,760.53 | -2,578,753.14 |
| 信用减值损失(新) | -959,927.35 | -1,293,469.92 | 337,550.33 | -2,315,196.38 |
| 其他收益 | 4,986,227.8 | 36,276,556.52 | 32,089,318.32 | 26,499,345.27 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 46,550,819.64 | 161,765,797.99 | 163,534,472.37 | 121,293,148.53 |
| 加:营业外收入 | 1,350 | 22,044.43 | 19,543.6 | 1,912.83 |
| 减:营业外支出 | 13,987.64 | 111,505.34 | 111,505.34 | 91,461.35 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 46,538,182 | 161,676,337.08 | 163,442,510.63 | 121,203,600.01 |
| 减:所得税费用 | 9,291,561.91 | 22,915,862.76 | 24,105,765.5 | 21,738,853.83 |
| 六、净利润 | 37,246,620.09 | 138,760,474.32 | 139,336,745.13 | 99,464,746.18 |
| 持续经营净利润 | 37,246,620.09 | 138,760,474.32 | 139,336,745.13 | 99,464,746.18 |
| 归属于母公司股东的净利润 | 41,213,565.38 | 164,317,286.38 | 158,409,039.22 | 112,793,471.26 |
| 少数股东损益 | -3,966,945.29 | -25,556,812.06 | -19,072,294.09 | -13,328,725.08 |
| (一)基本每股收益 | 0.44 | 1.75 | 1.69 | 1.2 |
| (二)稀释每股收益 | 0.44 | 1.75 | 1.69 | 1.2 |
| 九、综合收益总额 | 37,246,620.09 | 138,760,474.32 | 139,336,745.13 | 99,464,746.18 |
| 归属于母公司股东的综合收益总额 | 41,213,565.38 | 164,317,286.38 | 158,409,039.22 | 112,793,471.26 |
| 归属于少数股东的综合收益总额 | -3,966,945.29 | -25,556,812.06 | -19,072,294.09 | -13,328,725.08 |
| 公告日期 | 2025-04-22 | 2025-04-22 | 2024-10-29 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |